Story Poster
Photo by Bruce Waterfield/OSU Athletics
Oklahoma State Baseball

Two Cowboys Selected On Final Day of MLB Draft

July 13, 2021
453

DENVER – A pair of Oklahoma State pitchers were chosen on the final day of the 2021 Major League Baseball Draft Tuesday, bringing the total number of Cowboys selected in this year's draft to three.
 
On Monday, Christian Encarnacion-Strand was a fourth-round choice of Houston, and on Tuesday, Justin Wrobleski and Brett Standlee heard their names called. Wrobleski was an 11th-round pick (342nd overall) of the Los Angeles Dodgers, while Standlee was taken in the 17th round by the San Francisco Giants with the 506th overall pick.
 
OSU has now had 49 players selected in the MLB Draft in nine years under head coach Josh Holliday.
 
Each of the Cowboys selected in 2021 improved their previous draft status — Encarnacion-Strand was a 34th-round pick in 2019, Wrobleski was a 36th rounder in 2018 and Standlee was never previously drafted.  
 
In his first season in Stillwater in 2021, Wrobleski was part of OSU's weekend starting rotation and pitched in nine games before an injury ended his season in April; he underwent Tommy John surgery in late May. The southpaw went 3-2 with a 4.20 ERA for the Cowboys and racked up 50 strikeouts in 40 2/3 innings.
 
Standlee is coming off his third season with the Pokes and owns an 8-3 record, seven saves and a 3.69 ERA in 50 career appearances, 35 of those as a reliever. In 124 1/3 innings, he has recorded 116 strikeouts.
 
A right-hander, Standlee is coming off a 2021 season in which he was an All-Big 12 Second Team performer after going 4-1 with a 3.09 ERA and a team-high five saves. In 24 appearances, including a pair of starts, Standlee tallied 44 strikeouts in 32 innings. 

Discussion from...

Two Cowboys Selected On Final Day of MLB Draft

408 Views | 0 Replies | Last: 2 mo ago by Nativepoke918
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.